Actively Recruiting

Age: 60Years +
All Genders
ID07112573

Association Between Intake of Psychotropic Medications and Risk of Falls in Older Adults

Led by Ain Shams University · Updated on 2026-03-17

398

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to assess how taking psychotropic medications may be linked to a higher risk of falls in older adults discharged from Ain Shams University Geriatric Hospital. The study also looks at whether these falls lead to fractures as a secondary outcome. It includes both men and women aged 60 years and older, excluding those with cancer or who are bedridden. The study is designed as a prospective cohort study. It will collect baseline information retrospectively from medical records of patients admitted between July 2024 and June 2025. This data includes demographics, drug history, medication adherence measured by the Hill-Bone Medication Adherence Scale, previous falls, cognitive and psychological assessments, nutritional and functional status, and lab tests. After discharge, participants will be followed up by telephone one year later to check for any falls. Participants will provide information through their medical records and a follow-up phone call after one year. Researchers will monitor the occurrence of falls and fractures during this period. The main outcome measured is the association between psychotropic medication use and falls risk one year after hospital discharge. This study is sponsored by Ain Shams University and aims to provide valuable insight into fall risks in older adults taking these medications.

CONDITIONS

Brief Title

Association Between Intake of Psychotropic Medications and Risk of Falls in Older Adults

Who Can Participate

Age: 60Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 60 years or older
  • Both males and females who accept to participate in the study
Not Eligible

You will not qualify if you...

  • Patients with malignancy
  • Bedridden patients

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Baseline Data Collection

Duration - Up to 12 months

Participants' baseline data including socio-demographic information, medication history, and various assessments are collected retrospectively from medical records.

Long-term Monitoring

Duration - 1 year

Participants are followed up by telephone 1 year after hospital discharge to assess the occurrence of falls.

1 telephone follow-up

Trial Site Locations

Total: 1 location

1

Ain Shams University

Cairo, Abbassia, Egypt, 00202

Actively Recruiting

Loading map...

Research Team

M

Mariam Yasser Mohamed Safwat

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Subjective Experience of Psychotropic Drugs Among Adolescent...

Anorexia Nervosa

Actively Recruiting

1 location

National Pregnancy Registry for Psychiatric Medications

Pregnant Women

Actively Recruiting

1 location

Nebulized Ketamine for the Treatment of Major Depressive Dis...

Severe Depression

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here